Influenza Vaccination Increases Toxicity in PD-1/PD-L1 Immunotherapy Blockade for Lung Cancer – Oncology Nurse Advisor
Oncology Nurse Advisor |
Influenza Vaccination Increases Toxicity in PD-1/PD-L1 Immunotherapy Blockade for Lung Cancer
Oncology Nurse Advisor Although seasonal influenza vaccination produced good serologic protection and no observed short-term toxicity, it was associated with increased rates of immunologic toxicity in patients with lung cancer receiving PD-1/PD-L1 immunotherapy blockade. PD-Inhibitor Benefits 'Continue Beyond Progression' in NSCLC Immune Checkpoint Inhibitors are Here to Stay in NSCLC, Expert Says Checkpoint Inhibitors Improve Response to Salvage Chemotherapy in NSCLC |
